Literature DB >> 7970095

Choice of dialysis membrane does not influence the outcome of residual renal function in haemodialysis patients.

C Caramelo1, R Alcázar, P Gallar, J L Teruel, M Velo, O Ortega, A Galera, M Da Silva.   

Abstract

It has been recently proposed that haemodialysis membrane choice may influence the maintenance of residual renal function. The aim of the present study was to prospectively analyse the effect of membrane choice on the outcome of renal function in patients entering a chronic haemodialysis programme. Twenty-two patients from four hospitals have been randomly assigned to be dialysed with either polysulphone (PSF)/polyacrylonitrile (PAN) (group A; n = 9), or cuprophane membranes (group B; n = 13). Basal and monthly serum biochemistry, residual creatinine clearance (Ccr) and urine volume (Vu), pharmacological and dialytic treatment, diet, and haemodialysis-related complications were recorded. A significant decrease was observed in the two most relevant variables, i.e. remnant Ccr and Vu, within 3 months of starting haemodialysis, with stabilization during the further follow-up. Such decrease was similar (P NS) for both groups A and B throughout the 9-month observation period. In conclusion, our results suggest that the choice of haemodialysis membrane does not influence the outcome of the residual renal function. Renal function decreased significantly within 3 months on haemodialysis, independently of the type of dialyser membrane.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7970095     DOI: 10.1093/ndt/9.6.675

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  5 in total

Review 1.  High-flux versus low-flux membranes for end-stage kidney disease.

Authors:  Suetonia C Palmer; Kannaiyan S Rabindranath; Jonathan C Craig; Paul J Roderick; Francesco Locatelli; Giovanni F M Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

2.  Residual renal function and nutrition in young patients on chronic hemodialysis.

Authors:  Isabella Guzzo; Elvira Mancini; Séverin Kengne Wafo; Lucilla Ravà; Stefano Picca
Journal:  Pediatr Nephrol       Date:  2009-03-07       Impact factor: 3.714

Review 3.  Preservation of residual kidney function in hemodialysis patients: reviving an old concept.

Authors:  Anna T Mathew; Steven Fishbane; Yoshitsugu Obi; Kamyar Kalantar-Zadeh
Journal:  Kidney Int       Date:  2016-05-12       Impact factor: 10.612

Review 4.  Cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.

Authors:  A M Macleod; M Campbell; J D Cody; C Daly; C Donaldson; A Grant; I Khan; K S Rabindranath; L Vale; S Wallace
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

5.  Residual renal function in hemodialysis patients: the role of Angiotensin-converting enzyme inhibitor in its preservation.

Authors:  Dimitris Xydakis; Apostolos Papadogiannakis; Maria Sfakianaki; Konstantinos Kostakis; Konstantinos Stylianou; Ioannis Petrakis; Antonaki Ergini; Konstantinos Voskarides; Eugeneios Dafnis
Journal:  ISRN Nephrol       Date:  2012-12-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.